Medifast (Medifast) Total Inventories

: $55 Mil (As of Dec. 2023)

View and export this data going back to 1981. Start your Free Trial

Medifast's total inventories for the quarter that ended in Dec. 2023 was $55 Mil. Medifast's average total inventories from the quarter that ended in Sep. 2023 to the quarter that ended in Dec. 2023 was $56 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Medifast's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $6.32.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Medifast's Days Inventory for the three months ended in Dec. 2023 was 103.68.

Inventory Turnover measures how fast the company turns over its inventory within a year. Medifast's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.88.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Medifast's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.30.

Medifast Total Inventories Historical Data

The historical data trend for Medifast's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medifast Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

48.77

53.39

180.04

118.86

54.59

Medifast Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Inventories																118.86	96.90	68.90	58.23	54.59

Medifast Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Medifast (NYSE:MED) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Medifast's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

	Net-Net Working Capital Per Share (Q: Dec. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(150.041	+	0.75 * 0	+	0.5 * 54.591	-	108.427
-	0	-	0)	/	10.896
=	6.32

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Medifast's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	56.409	/	49.646	*	365 / 4
	=	103.68

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Medifast's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	49.646	/	56.409
	=	0.88

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Medifast's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	56.409	/	191.015
	=	0.30

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Medifast Total Inventories Related Terms

Thank you for viewing the detailed overview of Medifast's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Medifast (Medifast) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Medifast Inc (NYSE:MED) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

MED:Mexico MDF:Germany MDF:Germany

Address

100 International Drive, Baltimore, MD, USA, 21202

Website

https://www.medifastinc.com

Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.

Executives

Jeffrey J Brown	director	19900 MACARTHUR BLVD, SUITE 570, IRVINE CA 92612
Andrea B Thomas	director	C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Michael A. Hoer	director	MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Scott Schlackman	director	3600 CRONDALL LANE, OWINGS MILLS MD 21117
Hallquist Constance J.	director	3600 CRONDALL LANE, OWINGS MILLS MD 21117
Elizabeth A. Geary	director	C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Daniel R Chard	director, officer: Chief Executive Officer	NU SKIN ENTERPRISES, INC., 75 WEST CENTER STREET, PROVO UT 84601
Jonathan Barrett Mackenzie	officer: VP, Finance & CAO	100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Kevin G Byrnes	director	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Michael C Macdonald	director	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
James P. Maloney	officer: Chief Financial Officer	415 HOLIDAY DRIVE, PITTSBURGH PA 15220
Ming Xian	director	MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Carl E Sassano	director	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Joseph P Kelleman	officer: (Interim) CFO	3600 CRONDALL LANE, OWINGS MILLS MD 21117
Timothy G Robinson	officer: Chief Financial Officer	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117